SMLR - Semler Scientific GAAP EPS of $0.51 beats by $0.11 revenue of $14.83M beats by $0.12M
- Semler Scientific press release ( NASDAQ: SMLR ): Q2 GAAP EPS of $0.51 beats by $0.11 .
- Revenue of $14.83M (+3.6% Y/Y) beats by $0.12M .
- Cash and cash equivalents at June 30, 2022 increased to $40.0 million from $28.5 million.
- 2H Guidance: Revenue will range from $29.2 million to $31.2 million representing a growth rate of 14% to 21% compared to the second half of 2021
- Operating expenses will range from $22.8 million to $24.3 million.
- 2022 Guidance: Annual revenue will range from $58.0 million to $60.0 million, representing a growth rate of 9% to 14%
- Operating expenses will range from $42.5 million to $44.0 million. The guidance for operating expenses indicates less spending than previously anticipated due to greater efficiencies achieved in Semler Sceintific's sales organization during the first half of 2022.
For further details see:
Semler Scientific GAAP EPS of $0.51 beats by $0.11, revenue of $14.83M beats by $0.12M